Helfie is on an ambitious journey to develop a library of digital resilience biomarkers for disorders of gut-brain interaction (DGBI), previously known as functional gastrointestinal disorders.

DGBIs affect over 40%* of adults globally, and we are focusing on commonly reported disorders in primary care, such as lactose intolerance, coeliac disease, and irritable bowel syndrome.

These three disorders share symptoms, particularly changes in stool consistency. By analysing stool images, we can detect subtle changes and, combined with the Rome IV criteria and other clinical guidelines, differentiate between lactose intolerance, coeliac disease, and IBS at an early stage.

While it may seem unpleasant, your stool is a vital indicator of your gut health